BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 15378668)

  • 1. Serotonin and noradrenaline reuptake inhibitors in animal models of pain.
    Mochizucki D
    Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S15-9. PubMed ID: 15378668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral antinociceptive actions of desipramine and fluoxetine in an inflammatory and neuropathic pain test in the rat.
    Sawynok J; Esser MJ; Reid AR
    Pain; 1999 Aug; 82(2):149-158. PubMed ID: 10467920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The monoamine-mediated antiallodynic effects of intrathecally administered milnacipran, a serotonin noradrenaline reuptake inhibitor, in a rat model of neuropathic pain.
    Obata H; Saito S; Koizuka S; Nishikawa K; Goto F
    Anesth Analg; 2005 May; 100(5):1406-1410. PubMed ID: 15845695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
    Iyengar S; Webster AA; Hemrick-Luecke SK; Xu JY; Simmons RM
    J Pharmacol Exp Ther; 2004 Nov; 311(2):576-84. PubMed ID: 15254142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression.
    Brunello N; Mendlewicz J; Kasper S; Leonard B; Montgomery S; Nelson J; Paykel E; Versiani M; Racagni G
    Eur Neuropsychopharmacol; 2002 Oct; 12(5):461-75. PubMed ID: 12208564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of comorbid pain with serotonin norepinephrine reuptake inhibitors.
    Briley M; Moret C
    CNS Spectr; 2008 Jul; 13(7 Suppl 11):22-6. PubMed ID: 18622371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
    Jones CK; Eastwood BJ; Need AB; Shannon HE
    Neuropharmacology; 2006 Dec; 51(7-8):1172-80. PubMed ID: 17045620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats.
    Mochizuki D; Tsujita R; Yamada S; Kawasaki K; Otsuka Y; Hashimoto S; Hattori T; Kitamura Y; Miki N
    Psychopharmacology (Berl); 2002 Jul; 162(3):323-32. PubMed ID: 12122491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In the rat forced swimming test, chronic but not subacute administration of dual 5-HT/NA antidepressant treatments may produce greater effects than selective drugs.
    Rénéric JP; Bouvard M; Stinus L
    Behav Brain Res; 2002 Nov; 136(2):521-32. PubMed ID: 12429415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction between antidepressant drugs and the pain-relieving effect of spinal cord stimulation in a rat model of neuropathy.
    Song Z; Meyerson BA; Linderoth B
    Anesth Analg; 2011 Nov; 113(5):1260-5. PubMed ID: 21788322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The effectiveness of antidepressants in the treatment of chronic non-cancer pain--a review].
    Miller A; Rabe-Jabłońska J
    Psychiatr Pol; 2005; 39(1):21-32. PubMed ID: 15771151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noradrenaline and serotonin reuptake inhibition as clinical principles: a review of antidepressant efficacy.
    Humble M
    Acta Psychiatr Scand Suppl; 2000; 402():28-36. PubMed ID: 10901156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic effects of antidepressants on serotonin release in rat raphe slice cultures: high potency of milnacipran in the augmentation of serotonin release.
    Nagayasu K; Kitaichi M; Nishitani N; Asaoka N; Shirakawa H; Nakagawa T; Kaneko S
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2295-306. PubMed ID: 23920436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a role for a pure noradrenergic drug in the treatment of depression?
    Montgomery SA
    Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S3-9; discussion S71-3. PubMed ID: 9169305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 May; 2015(5):CD011681. PubMed ID: 25931277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine: a new selective and dual-acting antidepressant.
    Bauer M; Möller HJ; Schneider E
    Expert Opin Pharmacother; 2006 Mar; 7(4):421-7. PubMed ID: 16503814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intrathecal administration of newer antidepressants on mechanical allodynia in rat models of neuropathic pain.
    Ikeda T; Ishida Y; Naono R; Takeda R; Abe H; Nakamura T; Nishimori T
    Neurosci Res; 2009 Jan; 63(1):42-6. PubMed ID: 18992286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.